United-Guardian Q2 Sales Jump 10% on 44% Surge in Cosmetic Ingredient Demand
UG sits 28% above its 52-week low of $5.575 on light trading volume (0.1× avg).
Summary
United-Guardian reported Q2 net sales of $3.1 million, up 10% year-over-year, with net income rising 16% to $728,579 ($0.16 per share). The standout was a 44% jump in cosmetic ingredient sales, driven by Ashland Specialty Ingredients resuming regular purchasing after inventory reductions in 2025. Pharmaceutical sales edged up 1%, with Renacidin as the main growth driver. The company plans to expand promotional efforts for Renacidin in 2026. This follows a strong Q1 and a 20% dividend increase declared in July, signaling sustained momentum in its specialty ingredients business.
At the time of this announcement, UG was trading at $7.11 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $32.7M. The 52-week trading range was $5.58 to $8.78. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.